900120 — CXI Healthcare Technology Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapValue Trap

Annual income statement for CXI Healthcare Technology, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	545	377	377	297	239
Cost of Revenue
Gross Profit	153	149	162	89.2	56.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	511	340	274	247	224
Operating Profit	33.9	36.7	102	50.2	14.4
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	32.2	39.6	159	70.9	40.2
Provision for Income Taxes
Net Income After Taxes	32.2	39.6	159	65.7	38.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	32.2	39.6	159	65.7	38.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	31.8	39.6	159	65.7	38.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	70.1	62.3	153	55.2	29.3
Dividends per Share